Jacob Asset Management of New York LLC reduced its stake in shares of Schrödinger, Inc. (NASDAQ:SDGR – Free Report) by 21.6% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 6,896 shares of the company’s stock after selling 1,904 shares during the period. Jacob Asset Management of New York LLC’s holdings in Schrödinger were worth $344,000 as of its most recent SEC filing.
A number of other large investors have also made changes to their positions in the stock. Envestnet Asset Management Inc. acquired a new position in Schrödinger during the first quarter worth $312,000. US Bancorp DE grew its holdings in shares of Schrödinger by 69.2% in the first quarter. US Bancorp DE now owns 1,932 shares of the company’s stock valued at $66,000 after purchasing an additional 790 shares during the period. MetLife Investment Management LLC increased its position in Schrödinger by 58.5% during the first quarter. MetLife Investment Management LLC now owns 25,484 shares of the company’s stock worth $870,000 after purchasing an additional 9,405 shares during the last quarter. Rhumbline Advisers raised its stake in Schrödinger by 2.5% during the first quarter. Rhumbline Advisers now owns 46,592 shares of the company’s stock worth $1,590,000 after purchasing an additional 1,141 shares during the period. Finally, BlackRock Inc. boosted its holdings in Schrödinger by 2.6% in the 1st quarter. BlackRock Inc. now owns 3,205,108 shares of the company’s stock valued at $109,357,000 after purchasing an additional 81,435 shares during the last quarter. 81.14% of the stock is currently owned by hedge funds and other institutional investors.
Schrödinger Trading Down 0.1 %
Schrödinger stock traded down $0.02 during trading on Friday, hitting $30.86. The company had a trading volume of 956,688 shares, compared to its average volume of 872,460. The company’s 50 day simple moving average is $27.19 and its 200-day simple moving average is $35.72. Schrödinger, Inc. has a 1-year low of $15.85 and a 1-year high of $59.24. The stock has a market cap of $2.22 billion, a price-to-earnings ratio of 55.11, a price-to-earnings-growth ratio of 28.69 and a beta of 1.41.
Wall Street Analyst Weigh In
Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.
- Five stocks we like better than Schrödinger
- Are Penny Stocks a Good Fit for Your Portfolio?
- S&P 500’s Whirlwind: Big gains, warning whispers & tactical moves
- Basic Materials Stocks Investing
- MarketBeat Week in Review – 11/13 – 11/17
- Mega Cap Stocks: What They Are and How to Invest
- 3 large caps with red hot RSIs with upside
Receive News & Ratings for Schrödinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Schrödinger and related companies with MarketBeat.com's FREE daily email newsletter.